Dengue VLP protein (Serotype 2)


Catalog Number: B2012238 (100 ug)
Dengue VLP protein (Serotype 2) is a high quality recombinant Dengue VLP protein (Serotype 2). This product has been used as molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.

Live enquiry about this product via Text/SMS: 1-858-900-3210.

In stock

SKU: B2012238 Categories: , Tag:


Dengue VLP protein (Serotype 2)
Catalog number: B2012238
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 ug
Molecular Weight or Concentration: 0.5 mg/mL
Supplied as: Solution
Applications: molecular tool for various biochemical applications
Storage: -20°C
Keywords: DENV protein, Dengue protein, Dengue virus-like particles protein
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

1: Lin HH, Yip BS, Huang LM, Wu SC. Zika virus structural biology and progress in vaccine development Biotechnol Adv. 2018 Jan-Feb;36(1):47-53.
2: Imagawa T, Ito M, Matsuda M, Nakashima K, Tokunaga Y, Ohta I, Li TC, Suzuki R, Suzuki T. Virus-like particles with FLAG-tagged envelope protein as a tetravalent dengue vaccine candidate Sci Rep. 2021 Sep 2;11(1):17542.
3: Galula JU, Salem GM, Destura RV, Remenyi R, Chao DY. Comparable Accuracies of Nonstructural Protein 1- and Envelope Protein-Based Enzyme-Linked Immunosorbent Assays in Detecting Anti-Dengue Immunoglobulin G Antibodies Diagnostics (Basel). 2021 Apr 21;11(5):741.
4: Boigard H, Cimica V, Galarza JM. Dengue-2 virus-like particle (VLP) based vaccine elicits the highest titers of neutralizing antibodies when produced at reduced temperature Vaccine. 2018 Nov 29;36(50):7728-7736.
5: Cuevas-Juárez E, Pando-Robles V, Palomares LA. Flavivirus vaccines: Virus-like particles and single-round infectious particles as promising alternatives Vaccine. 2021 Nov 26;39(48):6990-7000.
6: Shang W, Liu J, Yang J, Hu Z, Rao X. Dengue virus-like particles: construction and application Appl Microbiol Biotechnol. 2012 Apr;94(1):39-46.
7: Warner NL, Frietze KM. Development of Bacteriophage Virus-Like Particle Vaccines Displaying Conserved Epitopes of Dengue Virus Non-Structural Protein 1 Vaccines (Basel). 2021 Jul 2;9(7):726.
8: Cimica V, Williams S, Adams-Fish D, McMahon C, Narayanan A, Rashid S, Stedman TT. Zika Virus-Like Particle (VLP) vaccine displaying Envelope (E) protein CD loop antigen elicits protective and specific immune response in a murine model Biochem Biophys Res Commun. 2020 Aug 27;529(3):805-811.
9: Hsieh SC, Tsai WY, Wang WK. The length of and nonhydrophobic residues in the transmembrane domain of dengue virus envelope protein are critical for its retention and assembly in the endoplasmic reticulum J Virol. 2010 May;84(9):4782-97.
10: Khetarpal N, Poddar A, Nemani SK, Dhar N, Patil A, Negi P, Perween A, Viswanathan R, Lünsdorf H, Tyagi P, Raut R, Arora U, Jain SK, Rinas U, Swaminathan S, Khanna N. Dengue-specific subviral nanoparticles: design, creation and characterization J Nanobiotechnology. 2013 May 25;11:15.

Products Related to Dengue VLP protein (Serotype 2) can be found at Proteins

Additional information

Weight 48 oz
Dimensions 8 × 8 × 8 in

How to Order

1- Order online using our website’s automated shopping cart and checkout system (available 24/7).

2- Order by email: (we accept electronic PO, available 24/7).

3- Order by Fax: 1-858-437-9884 (available 24/7).

4- Order by phone: 1-858-900-3210 (6 am – 8 pm PST).

5- Order by Text/SMS: 1-858-900-3210 (6 am – 8 pm PST).